Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

No evident neuronal damage after electroconvulsive therapy.

O C Zachrisson1, J Balldin, R Ekman

  • 1Institute of Clinical Neuroscience, Department of Psychiatry and Neurochemistry, Göteborg University, Göteborg, Sweden. olof.zachrisson@neuro.gu.se

Psychiatry Research
|November 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging Synaptic Vesicle Protein SV2C with <sup>18</sup>F-UCB-F: An In Vitro Autoradiography and In Vivo NHP PET Study.

ACS chemical neuroscience·2026
Same author

Brain injury biomarkers and intraoperative hypotension: associations with pituitary hormone deficiency following transsphenoidal endoscopic surgery for non-functioning pituitary adenomas.

Pituitary·2025
Same author

Unusually high spin-orbit coupling in the methionine singlet-triplet transition and the role of magnetic perturbations in amino acids.

Physical chemistry chemical physics : PCCP·2025
Same author

The impact of cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive decline.

medRxiv : the preprint server for health sciences·2025
Same author

The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life use.

Multiple sclerosis and related disorders·2025
Same author

Neuroinflammation in Parkinson's disease: A study with [<sup>11</sup>C]PBR28 PET and cerebrospinal fluid markers.

Parkinsonism & related disorders·2024
Same journal

Comparative efficacy and acceptability of pharmacological interventions for postpartum depression: a systematic review and network meta-analysis.

Psychiatry research·2026
Same journal

Measurements of suicidal ideation in ecological momentary assessment based on smartphone: a systematic review.

Psychiatry research·2026
Same journal

Effect of Australian telepsychiatry services on attention-deficit hyperactivity disorder prescriptions.

Psychiatry research·2026
Same journal

Cognitive correlates of Antisaccade Task performance in bipolar disorder.

Psychiatry research·2026
Same journal

National estimates of exposure to potentially traumatic events among individuals with obsessive-compulsive disorder: Findings from The National OCD Survey.

Psychiatry research·2026
Same journal

Digitally delivered cognitive bias modification for interpretation targeting hostile interpretation bias in compulsory drug rehabilitation: A feasibility randomized trial.

Psychiatry research·2026
See all related articles

Electroconvulsive therapy (ECT) for major depressive disorder did not show biochemical evidence of brain damage. This study found no significant changes in neuronal damage markers or blood-brain barrier function after ECT treatment.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Electroconvulsive therapy (ECT) is a highly effective treatment for major depressive disorder.
  • Concerns exist regarding potential cognitive deficits and brain damage associated with ECT.

Purpose of the Study:

  • To investigate whether ECT induces cerebral damage using biochemical markers.
  • To assess changes in neuronal/glial degeneration markers and blood-brain barrier (BBB) function post-ECT.

Main Methods:

  • Measured cerebrospinal fluid (CSF) concentrations of tau protein, neurofilament (NFL), and S-100 beta protein before and after ECT.
  • Determined the CSF/serum albumin ratio to evaluate BBB integrity.
  • Assessed depressive symptoms using the Montgomery-Asberg Rating Scale for Depression.

Related Experiment Videos

Main Results:

  • ECT treatment led to significant clinical improvement in depressive symptoms for all patients.
  • No significant changes were observed in CSF levels of tau, NFL, or S-100 beta after ECT.
  • The CSF/serum albumin ratio remained unchanged, indicating no ECT-induced BBB dysfunction.

Conclusions:

  • A therapeutic course of ECT did not result in biochemical evidence of neuronal or glial damage.
  • No indication of blood-brain barrier dysfunction was detected following ECT treatment.